I think it interesting that one of the directors increased his interest through a private company about September 2018. I think the purchases were about $400,000. He must have some confidence. Technogas has only been used on a limited type of procedure, lung function. From my understanding, ther is now also a market for diagnosis in relation to pulmonary embolism which is quite a separate area. If the approvals come through, the longer terms sales prospects are enhanced. It seems as if the US FDA approval process is a likely catalyst for increasing sales.
- Forums
- ASX - By Stock
- CYC
- Ann: FNN Interview and Presentation
Ann: FNN Interview and Presentation, page-27
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.42 |
Change
0.005(0.35%) |
Mkt cap ! $157.2M |
Open | High | Low | Value | Volume |
$1.42 | $1.42 | $1.41 | $14.02K | 9.894K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2483 | $1.42 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.43 | 2415 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2483 | 1.415 |
1 | 3894 | 1.400 |
1 | 738 | 1.355 |
1 | 741 | 1.350 |
2 | 4071 | 1.310 |
Price($) | Vol. | No. |
---|---|---|
1.430 | 2415 | 1 |
1.460 | 7000 | 1 |
1.500 | 8694 | 1 |
1.600 | 2941 | 1 |
1.715 | 1260 | 1 |
Last trade - 15.59pm 16/08/2024 (20 minute delay) ? |
Featured News
CYC (ASX) Chart |